Evidence map›Paper›PMID 35618739›Full record

Observational studyNPJ primary care respiratory medicine2022

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.

Janwillem W H Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Evgeni Dvortsin, Marina Garcia Pardo and 19 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in NPJ primary care respiratory medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.International journal of chronic obstructive pulmonary disease · 2023
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 10 countries.

Janwillem W H KocksGeneral Practitioners Research Institute, Groningen, The Netherlands. janwillem@gpri.nl.ORCID 0000-0002-2760-0693
Hans WoutersGeneral Practitioners Research Institute, Groningen, The Netherlands.
Sinthia Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.ORCID 0000-0001-5077-8329
Joyce van CootenGeneral Practitioners Research Institute, Groningen, The Netherlands.
Jaime Correia de SousaLife and Health Sciences Research Institute (ICVS), PT Government Associate Laboratory, School of Medicine, University of Minho, Braga, Portugal.ORCID 0000-0001-6459-7908
Biljana CvetkovskiWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.ORCID 0000-0003-2297-8141
Richard DekhuijzenRadboud University Medical Center, Nijmegen, The Netherlands.
Lars DijkGeneral Practitioners Research Institute, Groningen, The Netherlands.ORCID 0000-0002-9544-1487
Evgeni DvortsinGeneral Practitioners Research Institute, Groningen, The Netherlands.
Marina Garcia PardoPrimary Care Respiratory Research Unit, Instituto De Investigación Sanitaria De Baleares (IdISBa), Palma de Mallorca, Spain.ORCID 0000-0002-4183-8219
Asparuh GardevBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Radosław GawlikDepartment of Internal Medicine, Allergology, Clinical Immunology, Medical University of Silesia, Katowice, Poland.
Iris van Geer-PostmusGeneral Practitioners Research Institute, Groningen, The Netherlands.
Iris van der HamGeneral Practitioners Research Institute, Groningen, The Netherlands.ORCID 0000-0003-1054-3415
Marten HarbersGeneral Practitioners Research Institute, Groningen, The Netherlands.
Alberto de la HozBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Ymke JanseGeneral Practitioners Research Institute, Groningen, The Netherlands.
Marjan KerkhofGeneral Practitioners Research Institute, Groningen, The Netherlands.
Federico LavoriniDepartment of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.ORCID 0000-0002-3293-2123
Tiago MaricotoFaculty of Health Sciences, University of Beira Interior, Covilha, Portugal.ORCID 0000-0002-4201-9565
Jiska MeijerGeneral Practitioners Research Institute, Groningen, The Netherlands.
Boyd MetzGeneral Practitioners Research Institute, Groningen, The Netherlands.ORCID 0000-0002-7949-2559
David PriceObservational and Pragmatic Research Institute, Singapore, Singapore.ORCID 0000-0002-9728-9992
Miguel Roman-RodriguezPrimary Care Respiratory Research Unit, Instituto De Investigación Sanitaria De Baleares (IdISBa), Palma de Mallorca, Spain.
Kirsten SchuttelGeneral Practitioners Research Institute, Groningen, The Netherlands.ORCID 0000-0001-7346-6360
Nilouq StokerGeneral Practitioners Research Institute, Groningen, The Netherlands.ORCID 0000-0002-0023-6529
Ioanna TsiligianniDepartment of Social Medicine, Health Planning Unit, Faculty of Medicine, University of Crete, Rethymno, Greece.
Omar UsmaniAirway Disease, National Heart and Lung Institute (NHLI), Imperial College London and Royal Brompton Hospital, London, UK.
Marika T LevingGeneral Practitioners Research Institute, Groningen, The Netherlands.ORCID 0000-0002-2732-4406
General Practitioners Research Institute · NLBoehringer Ingelheim (Germany) · DEHealth Research Institute of the Balearic Islands · ESThe University of Sydney · AUAzienda Ospedaliero-Universitaria Careggi · ITMedical University of Silesia · PLRadboud University Nijmegen · NLRoyal Brompton Hospital · GBUniversity Medical Center Groningen · NLUniversity of Aberdeen · GBUniversity of Beira Interior · PTUniversity of Crete · GRUniversity of Minho · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to determine the associations of Peak Inspiratory Flow (PIF), inhalation technique and adherence with health status and exacerbations in participants with COPD using DPI maintenance therapy. This cross-sectional multi-country observational real-world study included COPD participants aged ≥40 years using a DPI for maintenance therapy. PIF was measured three times with the In-Check DIAL G16: (1) typical PIF at resistance of participant's inhaler, (2) maximal PIF at resistance of participant's inhaler, (3) maximal PIF at low resistance. Suboptimal PIF (sPIF) was defined as PIF lower than required for the device. Participants completed questionnaires on health status (Clinical COPD Questionnaire (CCQ)), adherence (Test of Adherence to Inhalers (TAI)) and exacerbations. Inhalation technique was assessed by standardised evaluation of video recordings. Complete data were available from 1434 participants (50.1% female, mean age 69.2 years). GOLD stage was available for 801 participants: GOLD stage I (23.6%), II (54.9%), III (17.4%) and IV (4.1%)). Of all participants, 29% had a sPIF, and 16% were shown able to generate an optimal PIF but failed to do so. sPIF was significantly associated with worse health status (0.226 (95% CI 0.107-0.346), worse units on CCQ; p = 0.001). The errors 'teeth and lips sealed around mouthpiece', 'breathe in', and 'breathe out calmly after inhalation' were related to health status. Adherence was not associated with health status. After correcting for multiple testing, no significant association was found with moderate or severe exacerbations in the last 12 months. To conclude, sPIF is associated with poorer health status. This study demonstrates the importance of PIF assessment in DPI inhalation therapy. Healthcare professionals should consider selecting appropriate inhalers in cases of sPIF.

Indexed as

AsthmaPulmonary Disease, Chronic ObstructiveAgedCross-Sectional StudiesDry Powder InhalersFemaleHealth StatusHumansMale

Identifiers

PMID35618739
PMCPMC9135702
OpenAlexW4281565639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.